Pharmaceutical Biotechnology: Advances in Experimental Medicine and Biology, cartea 655
Editat de Carlos A. Guzmán, Giora Z. Feuersteinen Limba Engleză Paperback – 25 feb 2012
The authors and editors hope that this compilation of reviews will help readers rapidly and completely update knowledge and understanding of the frontiers in pharmaceutical biotechnologies.
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 943.73 lei 6-8 săpt. | |
Springer – 25 feb 2012 | 943.73 lei 6-8 săpt. | |
Hardback (1) | 951.47 lei 6-8 săpt. | |
Springer – 17 aug 2009 | 951.47 lei 6-8 săpt. |
Din seria Advances in Experimental Medicine and Biology
- 9% Preț: 719.56 lei
- 5% Preț: 717.20 lei
- 20% Preț: 691.93 lei
- 5% Preț: 715.71 lei
- 5% Preț: 1113.83 lei
- 5% Preț: 1031.00 lei
- 15% Preț: 640.24 lei
- 5% Preț: 717.00 lei
- 5% Preț: 820.42 lei
- 5% Preț: 717.00 lei
- 5% Preț: 715.35 lei
- 5% Preț: 716.28 lei
- 5% Preț: 716.28 lei
- 15% Preț: 641.38 lei
- 20% Preț: 1161.71 lei
- 5% Preț: 1170.51 lei
- 18% Preț: 1119.87 lei
- 5% Preț: 1288.48 lei
- 5% Preț: 1164.67 lei
- 5% Preț: 1101.73 lei
- 18% Preț: 1123.67 lei
- 5% Preț: 1435.64 lei
- 20% Preț: 1044.10 lei
- 18% Preț: 946.39 lei
- 5% Preț: 292.57 lei
- 18% Preț: 957.62 lei
- 18% Preț: 1235.76 lei
- 5% Preț: 1231.55 lei
- 5% Preț: 1292.30 lei
- 5% Preț: 1102.10 lei
- 18% Preț: 1132.81 lei
- 5% Preț: 1165.19 lei
- 5% Preț: 1418.48 lei
- 5% Preț: 1305.63 lei
- 18% Preț: 1417.72 lei
- 18% Preț: 1412.99 lei
- 24% Preț: 806.15 lei
- 18% Preț: 1243.29 lei
- 5% Preț: 1429.44 lei
- 5% Preț: 1618.70 lei
- 5% Preț: 1305.12 lei
- 18% Preț: 1124.92 lei
- 5% Preț: 1097.54 lei
- 15% Preț: 649.87 lei
- 5% Preț: 1097.54 lei
- 18% Preț: 945.79 lei
- 5% Preț: 1123.13 lei
- 20% Preț: 816.43 lei
Preț: 943.73 lei
Preț vechi: 1150.89 lei
-18% Nou
Puncte Express: 1416
Preț estimativ în valută:
180.60€ • 187.41$ • 150.95£
180.60€ • 187.41$ • 150.95£
Carte tipărită la comandă
Livrare economică 15-29 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9781461429241
ISBN-10: 1461429242
Pagini: 280
Ilustrații: 276 p. 31 illus., 9 illus. in color.
Dimensiuni: 155 x 235 x 15 mm
Greutate: 0.4 kg
Ediția:2009
Editura: Springer
Colecția Springer
Seria Advances in Experimental Medicine and Biology
Locul publicării:New York, NY, United States
ISBN-10: 1461429242
Pagini: 280
Ilustrații: 276 p. 31 illus., 9 illus. in color.
Dimensiuni: 155 x 235 x 15 mm
Greutate: 0.4 kg
Ediția:2009
Editura: Springer
Colecția Springer
Seria Advances in Experimental Medicine and Biology
Locul publicării:New York, NY, United States
Public țintă
ResearchCuprins
Translational Medicine—A Paradigm Shift in Modern Drug Discovery and Development: The Role of Biomarkers.- Natural Products in Drug Discovery: Present Status and Perspectives.- Protein Pharmaceuticals: Discovery and Preclinical Development.- The Role of Nanobiotechnology in Drug Discovery.- Conotoxin Venom Peptide Therapeutics.- Shark Novel Antigen Receptors—The Next Generation of Biologic Therapeutics?.- Immune Interventions of Human Diseases through Toll-Like Receptors.- Genome-Based Vaccine Development: A Short Cut for the Future.- The Antigenome: From Protein Subunit Vaccines to Antibody Treatments of Bacterial Infections?.- HSV as a Vector in Vaccine Development and Gene Therapy.- Virus-Like Particles as a Vaccine Delivery System: Myths and Facts.- Applications of Bacterial Ghosts in Biomedicine.- Immune Modulators with Defined Molecular Targets: Cornerstone to Optimize Rational Vaccine Design.- Innovative Approaches to Develop Prophylactic and Therapeutic Vaccines against HIV/AIDS.- New Strategies to Overcome the Drawbacks of Currently Available Flu Vaccines.
Notă biografică
Carlos A. Guzmán, MD, PhD is Head of the Department of Vaccinology and Applied Microbiology at the Helmholtz Centre for Infection Research (Braunschweig, Germany) and APL-Professor at the Medical School of Hannover. He is also German Coordinator for the International Doctorate in “Experimental Oncology” and Chair for “Vaccines & Antiinfectives” from the Indo-German Science Centre for Infectious Diseases. He graduated in Medicine at the National University of Rosario and obtained his Board Certification in Medical Bacteriology in Argentina. Then he moved to the Institute of Microbiology at the University of Genoa (Italy), as Research Fellow of the Italian Foreign Office Ministry. In Italy he also graduated as Doctor of Medicine and Surgery and obtained his Doctorate of Research in Microbiological Sciences. In 1994 he moved to Germany, where he became Head of the Vaccine Research Group at the German Research Centre for Biotechnology. He has been working in the field of vaccinology since 1989. His work has been instrumental for the development of new adjuvants, and the establishment of Salmonella spp. as a delivery system for DNA vaccines and therapeutic molecules. He has published more than 150 topic-related papers in international peer-reviewed journals and is co-inventor in several international patents. He is member of the Editorial Boards of Infection and Immunity, Microbial Biotechnology, Open Immunology Journal, Current Immunology Reviews, Open Vaccine Journal and Open Microbiology Journal, and Associate Editor of Human Vaccines.
Giora Z. Feuerstein, MD, MSc, FAHA is Assistant Vice President and Head of Discovery Translational Medicine, Wyeth Research. Prior to joining Wyeth, Dr. Feuerstein has maintained Executive Directorship position in discovery of cardiovascular, stroke, thrombosis and metabolic disease programs for 16 years in SmithKline Beecham,DuPont Pharma and Merck USA. Dr. Feuerstein led the discovery program of Carvedilol (COR EG) for heart failure, eprosartan for hypertension and many development programs in stroke, anti-arrhythmics, thrombosis and metabolic diseases. Dr. Feuerstein serves as Editor, Biochemical Pharmacology, editorial boards of Journal of Pharmacology and Experimental Therapeutics, Journal of Cerebral Blood Flow Metabolism, Circulation Research, and Stroke. Dr. Feuerstein is the recipient of several national and international awards including Award of Excellent in Cardiovascular Research, AHA; Prix Galien Award for Drug Discovery (endothelin antagonist), Conrad R. Lam Award for cardiovascular research, Henry Ford Foundation and Wyeth R&D President award. Giora Feuerstein has authored and coauthored over 400 peer-reviewed publications and is co-inventor on 12 patents.
Giora Z. Feuerstein, MD, MSc, FAHA is Assistant Vice President and Head of Discovery Translational Medicine, Wyeth Research. Prior to joining Wyeth, Dr. Feuerstein has maintained Executive Directorship position in discovery of cardiovascular, stroke, thrombosis and metabolic disease programs for 16 years in SmithKline Beecham,DuPont Pharma and Merck USA. Dr. Feuerstein led the discovery program of Carvedilol (COR EG) for heart failure, eprosartan for hypertension and many development programs in stroke, anti-arrhythmics, thrombosis and metabolic diseases. Dr. Feuerstein serves as Editor, Biochemical Pharmacology, editorial boards of Journal of Pharmacology and Experimental Therapeutics, Journal of Cerebral Blood Flow Metabolism, Circulation Research, and Stroke. Dr. Feuerstein is the recipient of several national and international awards including Award of Excellent in Cardiovascular Research, AHA; Prix Galien Award for Drug Discovery (endothelin antagonist), Conrad R. Lam Award for cardiovascular research, Henry Ford Foundation and Wyeth R&D President award. Giora Feuerstein has authored and coauthored over 400 peer-reviewed publications and is co-inventor on 12 patents.